Back
CSPC Stock Rises 5.4% After China Accepts New Diabetes Drug Application
Back
Stock News
Themes
CSPC Stock Rises 5.4% After China Accepts New Diabetes Drug Application
CSPC Stock Rises 5.4% After China Accepts New Diabetes Drug Application
Edgen Stock
·
Jan 13 2026, 06:33
Share to
Share to
Copy link
CSPC PHARMA
+0.10%
source:
[1] CSPC Pharmaceutical Group (01093)'s innovative drug marketing application accepted by the National Medical Products Administration; stock repeatedly rises by about 5%
Recommend
Hong Kong Refinancing Jumps 26-Fold to HK$26 Billion
Jan 18 2026, 22:25
Meta's $72B Spending Plan Draws Scrutiny as BofA Sets $810 Target
Jan 18 2026, 22:03
Bloom Energy Stock Gains 72% on Data Center Demand
Jan 18 2026, 21:55
Edgen Stock·Jan 13 2026, 06:33Edgen Stock·Jan 13 2026, 06:33
Edgen Stock·Jan 13 2026, 06:33